Roland Sänger

1.1k total citations
24 papers, 881 citations indexed

About

Roland Sänger is a scholar working on Epidemiology, Microbiology and Hepatology. According to data from OpenAlex, Roland Sänger has authored 24 papers receiving a total of 881 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 10 papers in Microbiology and 7 papers in Hepatology. Recurrent topics in Roland Sänger's work include Bacterial Infections and Vaccines (10 papers), Pneumonia and Respiratory Infections (9 papers) and Influenza Virus Research Studies (8 papers). Roland Sänger is often cited by papers focused on Bacterial Infections and Vaccines (10 papers), Pneumonia and Respiratory Infections (9 papers) and Influenza Virus Research Studies (8 papers). Roland Sänger collaborates with scholars based in Germany, Belgium and United Kingdom. Roland Sänger's co-authors include Ralf Clemens, Lode Schuerman, Fred Zepp, Achim Kaufhold, Hans L. Bock, Jeanne‐Marie Jacquet, Pirmin Habermehl, Claudius U. Meyer, Wolfgang Jilg and Peter M. Schneider and has published in prestigious journals such as PEDIATRICS, Journal of Hepatology and The Journal of Pediatrics.

In The Last Decade

Roland Sänger

23 papers receiving 816 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roland Sänger Germany	19	697	274	265	184	144	24	881
Ulrich Behre Germany	16	695 1.0×	156 0.6×	118 0.4×	244 1.3×	98 0.7×	27	899
Kyung‐Hyo Kim South Korea	18	843 1.2×	412 1.5×	67 0.3×	180 1.0×	68 0.5×	70	1.0k
Olivier Van Der Meeren Belgium	15	550 0.8×	328 1.2×	208 0.8×	217 1.2×	75 0.5×	40	709
Allan M. Arbeter United States	21	736 1.1×	97 0.4×	51 0.2×	150 0.8×	139 1.0×	39	936
F Ambrosch Austria	16	545 0.8×	66 0.2×	415 1.6×	261 1.4×	154 1.1×	51	811
Staffan Sylvan Sweden	16	410 0.6×	82 0.3×	230 0.9×	174 0.9×	114 0.8×	55	603
Veronik Hutse Belgium	17	644 0.9×	46 0.2×	214 0.8×	302 1.6×	137 1.0×	43	932
Lindsay R. Grant United States	22	857 1.2×	237 0.9×	38 0.1×	225 1.2×	101 0.7×	65	1.2k
J.P. Chiron France	13	597 0.9×	38 0.1×	397 1.5×	185 1.0×	101 0.7×	47	774
Christine Blondeau France	13	308 0.4×	171 0.6×	35 0.1×	191 1.0×	125 0.9×	20	606

Countries citing papers authored by Roland Sänger

Since Specialization

Citations

This map shows the geographic impact of Roland Sänger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roland Sänger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roland Sänger more than expected).

Fields of papers citing papers by Roland Sänger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roland Sänger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roland Sänger. The network helps show where Roland Sänger may publish in the future.

Co-authorship network of co-authors of Roland Sänger

This figure shows the co-authorship network connecting the top 25 collaborators of Roland Sänger. A scholar is included among the top collaborators of Roland Sänger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roland Sänger. Roland Sänger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baras, Benoı̂t, Jeanne‐Marie Devaster, Louis Fries, et al.. (2008). A vaccine manufacturer’s approach to address medical needs related to seasonal and pandemic influenza viruses. Influenza and Other Respiratory Viruses. 2(6). 251–260. 38 indexed citations

Rümke, H. C., José-María Bayas, Jan Hendrik Richardus, et al.. (2008). Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial. Vaccine. 26(19). 2378–2388. 81 indexed citations

Sänger, Roland, et al.. (2007). Booster vaccination and 1-year follow-up of 4–8-year-old children with a reduced-antigen-content dTpa-IPV vaccine. European Journal of Pediatrics. 166(12). 1229–1236. 23 indexed citations

Schmidt‐Ott, Ruprecht, Tino F. Schwarz, Rainer Haase, et al.. (2007). Immunogenicity and reactogenicity of a trivalent influenza split vaccine in previously unvaccinated children aged 6–9 and 10–13 years. Vaccine. 26(1). 32–40. 21 indexed citations

Meurice, François, et al.. (2006). Persistence of Antibodies in Children Primed with Two Different Hexavalent Diphtheria, Tetanus, Acellular Pertussis, Hepatitis B, Inactivated Poliovirus and Haemophilus influenzae Type b Vaccines and Evaluation of Booster Vaccination. Human Vaccines. 2(6). 249–254. 27 indexed citations

Knuf, Markus, Pirmin Habermehl, Jörg Faber, et al.. (2006). Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life. Vaccine. 24(27-28). 5627–5636. 13 indexed citations

Heininger, Ulrich, Roland Sänger, Jeanne‐Marie Jacquet, & Lode Schuerman. (2006). Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate combination vaccine in the second year of life: Safety, immunogenicity and persistence of antibody responses. Vaccine. 25(6). 1055–1063. 31 indexed citations

Behre, Ulrich, et al.. (2005). Immunogenicity and Reactogenicity of Four Doses of Diphtheria-Tetanus-Three-Component Acellular Pertussis-Hepatitis B-Inactivated Polio Virus-Haemophilus influenzae Type b Vaccine Coadministered with 7-Valent Pneumococcal Conjugate Vaccine. The Pediatric Infectious Disease Journal. 24(1). 70–77. 73 indexed citations

Schmidtke, Peter, Pirmin Habermehl, Markus Knuf, et al.. (2005). Cell mediated and antibody immune response to inactivated hepatitis A vaccine. Vaccine. 23(44). 5127–5132. 29 indexed citations

10.

Maier, Reinhard, et al.. (2005). Comparison of the immunogenicity and reactogenicity of two commercially available hexavalent vaccines administered as a primary vaccination course at 2, 4 and 6 months of age. Vaccine. 23(25). 3272–3279. 31 indexed citations

11.

Hoehler, Thomas, Ashish C. Shrestha, Beate Stradmann‐Bellinghausen, et al.. (2004). 23 The strength of hepatitis B surface antigen specific immune response is strongly influenced by the presence of complement factor C4A deficiencies. Journal of Hepatology. 40. 9–9.

12.

Zepp, Fred, Markus Knuf, Ulrich Heininger, et al.. (2003). Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants. Vaccine. 22(17-18). 2226–2233. 42 indexed citations

13.

Nothdurft, Hans Dieter, Jane N. Zuckerman, Jürgen Knobloch, et al.. (2002). A new accelerated vaccination schedule for rapid protection against hepatitis A and B. Vaccine. 20(7-8). 1157–1162. 55 indexed citations

14.

Höhler, Thomas, Beate Stradmann‐Bellinghausen, Roland Sänger, et al.. (2002). C4A deficiency and nonresponse to hepatitis B vaccination. Journal of Hepatology. 37(3). 387–392. 55 indexed citations

15.

Schmitt, Heinz J., et al.. (2000). Primary vaccination of infants with diphtheria-tetanus-acellular pertussis–hepatitis B virus– inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections. The Journal of Pediatrics. 137(3). 304–312. 63 indexed citations

16.

Kallinowski, B., Antje Knöll, Roland Sänger, et al.. (2000). Can monovalent hepatitis A and B vaccines be replaced by a combined hepatitis A/B vaccine during the primary immunization course?. Vaccine. 19(1). 16–22. 26 indexed citations

17.

Höhler, Thomas, Claudius U. Meyer, Arman Notghi, et al.. (1998). The Influence of Major Histocompatibility Complex Class II Genes and T-Cell Vβ Repertoire on Response to Immunization with HBsAg. Human Immunology. 59(4). 212–218. 54 indexed citations

18.

Clemens, Ralf, et al.. (1997). Booster immunization of low- and non-responders after a standard three dose hepatitis B vaccine schedule—results of a post-marketing surveillance. Vaccine. 15(4). 349–352. 74 indexed citations

19.

Bock, Hans L., Thomas Löscher, N. Scheiermann, et al.. (1995). Accelerated Schedule for Hepatitis B Immunization. Journal of Travel Medicine. 2(4). 213–217. 47 indexed citations

20.

Rosenfield, R. E., et al.. (1953). A "New" Rh Antibody, Anti-f. BMJ. 1(4817). 975–975. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact